Fiore files Rule 144 to sell 2,470 RSUs

Michael Fiore reports proposed Rule 144 sale of 2,470 Restricted Stock Units and recent 10b5-1 sales of 3,142 shares.

Rhea-AI Filing Summary

Michael Fiore reports proposed Rule 144 sale of 2,470 Restricted Stock Units and recent 10b5-1 sales of 3,142 shares. The filing lists 2,470 Restricted Stock Units with an effective date of 04/01/2026. It also records 10b5-1 sales of 3,142 Common shares on 05/29/2026 for $298,490. The listing shows Morgan Stanley Smith Barney LLC as the broker for the transactions. Timing and additional proceeds treatment beyond the amounts shown are not included in the excerpt.

Insights

Compliance Counsel

Rule 144 notice for sale of restricted units plus reported 10b5-1 disposals.

The filing shows a Rule 144 notification for 2,470 Restricted Stock Units dated 04/01/2026 and separate 10b5-1 sales of 3,142 Common shares on 05/29/2026 totaling $298,490. This combination is typical when previously restricted awards become eligible for resale under Rule 144 and when holders use pre-arranged trading plans for orderly dispositions.

Confirmatory items to watch in subsequent filings include whether the restricted units convert to shares and any broker settlement details; the excerpt lists Morgan Stanley Smith Barney LLC as broker.

Equity Compensation Analyst

Transaction is a routine disposition tied to RSUs and a 10b5-1 plan, not a material corporate event.

The record shows 2,470 Restricted Stock Units identified as issuer securities and an executed 10b5-1 sale of 3,142 shares for $298,490. Such items usually reflect employee or affiliate liquidity rather than operational changes.

Subsequent disclosures may clarify whether RSUs convert to shares and the net proceeds flow; current excerpt provides the core quantities and dates.

Key Figures

Restricted Stock Units to be sold: 2,470 units 10b5-1 shares sold: 3,142 shares Proceeds reported for 10b5-1 sale: $298,490 +1 more

4 metrics

Restricted Stock Units to be sold 2,470 units effective <date>04/01/2026</date>

10b5-1 shares sold 3,142 shares sale date <date>05/29/2026</date>

Proceeds reported for 10b5-1 sale $298,490 10b5-1 sale on <date>05/29/2026</date>

Broker listed Morgan Stanley Smith Barney LLC broker for the transactions

Key Terms

Rule 144, Restricted Stock Units, 10b5-1

3 terms

Rule 144 regulatory

"Security to be sold listed as Restricted Stock Units under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Securities To Be Sold: Restricted Stock Units, 2,470, 04/01/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 regulatory

"10b5-1 Sales for MICHAEL FIORE recorded on 05/29/2026"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Michael Fiore report in the Form 144 for HQY?

The Form 144 lists a proposed sale of 2,470 Restricted Stock Units dated 04/01/2026, and prior 10b5-1 sales of 3,142 Common shares on 05/29/2026 for $298,490.

How many shares were sold under the 10b5-1 plan reported in the filing?

The filing records 3,142 Common shares sold on 05/29/2026 under a 10b5-1 arrangement, with gross proceeds shown as $298,490 in the excerpt provided.

What type of securities are being offered under Rule 144 in this filing?

The filing identifies Restricted Stock Units as the securities to be sold, specifically 2,470 Restricted Stock Units with an effective date of 04/01/2026 shown in the excerpt.

Which broker is listed for the transactions in the Form 144?

Morgan Stanley Smith Barney LLC is listed as the broker in the filing excerpt, shown with its address and associated with the reported securities transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002016116
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHEQUITY, INC.
SEC File Number	001-36568
Address of Issuer	15 West Scenic Pointe Drive, Suite 100 Draper UTAH 84020
Phone	8017271000
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL FIORE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2470	227956.30	83602157	07/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2026	Restricted Stock Units	Issuer			2470	04/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL FIORE 15 West Scenic Pointe Drive, Suite 100 Draper UT 84020	Common	05/29/2026	3142	298490.00

144: Remarks and Signature

Remarks
Date of Notice	07/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Fiore
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)